Compare Cardinal Health Inc (CAH) vs VanEck Australian Floating Rate ETF (FLOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs VanEck Australian Floating Rate ETF — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while VanEck Australian Floating Rate ETF trades at $50.97. The key difference: Cardinal Health Inc pays a 0.89% dividend while VanEck Australian Floating Rate ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, VanEck Australian Floating Rate ETF nearer its low. Which is the better fit depends on your goals.
| CAH | FLOT | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Sector/Thematic |
52-Week High | $239.71 | $51.09 |
52-Week Low | $146.04 | $50.72 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
FLOT trades at $50.98 with no recent price change. Technical indicators show a bullish moving average signal but bearish oscillators, with the 6-day RSI at 88.89 indicating overbought conditions. Recent dividends of $0.17 and $0.18 per share reflect income distribution. The ETF focuses on high-quality floating rate bonds, offering a 4.0% SEC yield, with potential upside if the Federal Reserve raises rates.
The outlook for FLOT is tied to interest rate movements, with potential gains from rising yields but risks from inflation and geopolitical tensions. Investors seeking short-term income may find value, though overbought technicals suggest caution. Credit quality remains high, but macroeconomic shifts could impact performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About VanEck Australian Floating Rate ETF
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →
